An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) will report financial results for the three and six months ended June 30, 2023 after market close on Thursday, August 10, 2023. An investment community conference call will be held on the same day at 4:30 p.m. Eastern time. Participants can pre-register for the conference call to gain immediate access and bypass the live operator. The live webcast of the conference call will be available on the Company website. A replay of the call will be available until August 31, 2023.
Positive
None.
Negative
None.
EMERYVILLE, Calif.--(BUSINESS WIRE)--
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2023 after market close on Thursday, August 10, 2023 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.
Date/Time:
Thursday, August 10, 4:30 p.m. ET / 1:30 p.m. PT
Pre-Registration:
Participants can pre-register for the conference call here:
Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
Dial In:
Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call:
866-777-2509 from within the U.S.
412-317-5413 from outside the U.S.
The live webcast of the conference call also will be available on the Events section of the Company website. A replay of the call will be available beginning two hours after its completion through August 31, 2023 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 8198065. The webcast will also be archived here.
About NovaBay Pharmaceuticals, Inc:
NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and skincare products. NovaBay’s leading product, Avenova® Antimicrobial Lid & Lash Solution, is often prescribed by eyecare professionals for blepharitis and dry-eye disease and is also available directly to eyecare consumers through online distribution channels such as Amazon. DERMAdoctor® offers more than 30 dermatologist-developed skincare products through the DERMAdoctor website, well-known traditional and digital beauty retailers, and international distributors. NovaBay also manufactures and sells effective, yet gentle and non-irritating wound care products. The PhaseOne® brand is distributed through commercial partners in the U.S. for professional use only, and the NeutroPhase® brand is distributed in China by Pioneer Pharma (Hong Kong) Company Ltd.
Socialize and Stay Informed on NovaBay’s Progress
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website
Avenova Purchasing Information
For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com
Avenova.com
When will NovaBay Pharmaceuticals report its financial results for the three and six months ended June 30, 2023?
NovaBay Pharmaceuticals will report its financial results for the three and six months ended June 30, 2023 after market close on Thursday, August 10, 2023.
When will the investment community conference call be held?
The investment community conference call will be held on Thursday, August 10, 2023, beginning at 4:30 p.m. Eastern time.
How can participants pre-register for the conference call?
Participants can pre-register for the conference call by visiting the provided link in the press release. Pre-registered participants will receive a conference passcode and unique PIN for immediate access to the call.
How can participants access the live conference call without pre-registering?
Participants who choose not to pre-register can access the live conference call by dialing the provided numbers and requesting the NovaBay Pharmaceuticals call.
Where can the live webcast of the conference call be accessed?
The live webcast of the conference call can be accessed on the Events section of the NovaBay Pharmaceuticals website.
How long will the replay of the conference call be available?
The replay of the conference call will be available until August 31, 2023. Participants can access it by dialing the provided numbers and entering the conference ID.
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
